Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia

BACKGROUND AND AIMS: Thrombocytopenia is a common hematological abnormality observed in patients infected with hepatitis C virus (HCV). The use of eltrombopag has been approved for HCV-associated thrombocytopenia. This is the first study aiming to determine the predictive factors of response to eltr...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ther Clin Risk Manag
Главные авторы: Elbedewy, Tamer A, Elsebaey, Mohamed A, Elshweikh, Samah A, Elashry, Heba, Abd-Elsalam, Sherief
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2019
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6375108/
https://ncbi.nlm.nih.gov/pubmed/30804674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S186106
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы